Windtree Announces Notice of Permission of US Patent and
WARRINGTON, Pa., Oct. 25, 2022 (GLOBE NEWSWIRE) — Windtree Therapeutics, Inc. WINT, a biotechnology company focused on advancing multiple late-stage interventions in acute cardiovascular disease,